Gov. Wes Moore (D) signed HB 76 and SB 18, legislation that allows pharmacists to provide routine childhood vaccines to children ages 7 years and older. Both measures became effective upon signature.
Also in Maryland, effective May 1, 2024, Depakote Sprinkle Capsule (divalproex sprinkle capsule) is no longer preferred over its respective generic equivalent. Claims for the brand will now adjudicate only if there is a prior authorization based on an approved Maryland Department of Health (MDH) MedWatch form.
Finally in Maryland, the Prescription Drug Affordability Board will consider placing price caps on eight drugs soon, including the weight-loss and diabetes drug Ozempic, the attention-deficit/hyperactivity disorder (ADHD) drug Vyvance and an asthma medication called Dupixent. The drugs on the list cost more than $30,000 a year, meeting the board’s criteria as cost prohibitive. (WYPR)
For more information, contact NACDS’ Jill McCormack at 717-592-8977.